Archive for October, 2013

Fear may be the greatest predictor of disability status

Last week, we discussed some of the psychological components of pain, and the potent effect emotion and attitude can have on the day-to-day management of your pain.  Many patients coping with chronic pain experience kinesiophobia, an irrational fear of reinjuring oneself or exacerbating pain by participating in physical activity.

One study of patients with foot and ankle pain found that out of movement-related fear, pain intensity, and range of motion deficit, fear was by far the greatest predictor of disability status (http://1.usa.gov/1fXzxN5).  Clearly, fear of movement plays an important role in the quality of life of patients living with pain.Dr. Norman Marcus-disability status

Managing pain more successfully as reflected in continuing to work and be involved in life  is associated with less fear than those with lower levels of functioning when all other metrics are also considered.  A review of seven studies which examined patients with chronic musculoskeletal pain who chose to continue working found that these patients were significantly more likely to have low scores for both emotional distress and perceived disability (http://1.usa.gov/H4v9gc).

Treatments that address both the physical and emotional aspects of pain can produce better outcomes.  A study of 130 patients who had undergone a spinal fusion found that patients who participated in a rehabilitation program that included cognitive-behavioral therapy to address  kinesiophobia and catastrophizing as well therapeutic exercise faired significantly better than those who participated in a program consisting only of therapeutic exercise.  The psychological intervention was found to reduce dysfunctional thoughts and enhance quality of life for up to one year after treatment ended (http://1.usa.gov/17M2T91).

It is apparent that attitude – especially beliefs about movement – impacts the quality of life for patients in pain.  Those who maintain a positive outlook and a healthy perspective on movement, though not necessarily reporting reduced levels of pain, do show an increase in function.

Share

Norman Marcus Pain Institute-mood and painSeveral different variables have been studied: Catastrophizing, depression, kinesiophobia, and self-efficacy.

Catastrophizing is a type of dysfunctional thought in which the patient exaggerates the severity of a situation. Examples of catastrophizing are thoughts like “I can’t take it!” “What did I do to deserve this?” “What’s the use?”  “I might as well be dead!” One study of patients entering a multidisciplinary pain treatment center found that the extent to which a patient catastrophized was a better predictor of disability status than pain intensity (http://bit.ly/1aVCGa6).  A separate study of fibromyalgia patients found that pain catastrophizing was correlated with an increase in brain activity in areas related to attention to pain, anticipation of pain, and motor control (http://bit.ly/17y4Up8).  This suggests that catastrophizing affects the intensity with which patients perceive pain.

Depression and chronic pain often coexist.  Both conditions can markedly affect a patient’s health, motivation, and overall quality of life.  Patients with depression often experience feelings of helplessness, fatigue, and hopelessness – all feelings which can impair treatment outcome.  Depression and pain are also linked biologically through 2 common pathways:  the serotonergic and noradrenergic systems (http://bit.ly/1gqi29f).  The neurotransmitters serotonin and norepinephrine modulate pain transmission and also play key roles in the development of depression.  Therefore, treatments that target these neurotransmitters, such as tricyclic antidepressants, and SNRIs (serotonin/norepinephrine reuptake inhibitors) can be helpful for both conditions (http://bit.ly/1fID6GQ).

Kinesiophobia is fear of movement based on the belief that activity will result in re-injury or exacerbation of pain. Hi kinesiophobia scales result in less activity and interfere in effective rehabilitation (http://bit.ly/19RClca).  Depression often co-exists with kinesiophobia.

Self-efficacy in the context of chronic pain refers to confidence in one’s ability to cope and function despite persistent pain.   A study of patients with an acute whiplash injury found that patients with less belief in their ability to manage their life in the face of pain were significantly more likely to have their injury develop into a chronic condition (http://bit.ly/1bylac/).  A separate study of 45 low back pain patients found that higher self-efficacy predicted better overall functioning and decreased levels of pain at 6 month follow-up (http://bit.ly/19RClca).

Psychological factors play an important role in evaluating and treating pain.  When usual treatment is not progressing well, assessment and treatment of emotional factors may help the patient succeed in finding pain relief.

Share

One of our colleagues, Ronnie Gonzalez, a bereavement counselor, sent us a comment about her clients, who often felt physical pain while struggling with the loss of a loved one.

Very often, emotional stress and negative thoughts can manifest physically as tension in the muscles, which is one of the most common causes of pain. Constant exposure to stressors can cause the development of musculoskeletal pain in even healthy individuals (http://psycnet.apa.org/journals/ocp/15/4/399/, http://iospress.metapress.com/content/w8147125250687x5/) and is therefore considered a risk factor associated with the onset of pain.

fMRI (functional magnetic resonance imaging) studies of pain patients demonstrate that negative thoughts can excite areas of the brain associated with pain perceptions and intensify the sensation of pain. Studies have shown that painful muscles which are tense, especially during times of stress, can stay contracted and tight even after the stress or negative feelings are long gone. This causes the body to be more susceptible to pain.

Breathing and stress are also linked. When we suppress our feelings, we generally hold our breath. Depriving our muscles of oxygen will cause it to hurt. The advice of taking deep breaths when we’re stressed or anxious is not unfounded.

Share

We see that in some patients who have central sensitization, treating the peripheral pain generators may results in a decrease or elimination of the widespread pain.

Widespread pain is often addressed with medication. It is common for a patient to be given an anticonvulsant, such as pregabalin (Lyrica) or gabapentin (Neurontin), or a serotonin-norepinephrine reuptake inhibitors (SNRIs), such as duloxetine (Cymbalta) or venlafaxine (Effexor).  These drugs affect the neurons transmitting pain-related signals in the central nervous system.nerve bundle-Norman Marcus Pain Institute blog

Another possible target in the nervous system is the glial cells. The glia are non-neuronal cells that provide support and protection for the neurons.  90% of the central nervous system (spine and brain) are made up of glial cells.

Two cells types, microglia and astrocytes, recently have been found to play a role in pain processing. These two types of cells are stimulated in response to damaged or dying cells. Astrocytes produce inflammation, while microglia initiate both inflammatory and anti-inflammatory activity. An inflammatory response in the microglia results in pain-producing chemicals, adding to the patient’s overall pain. Chronic pain and opioids, such as morphine and oxycodone, can also stimulate the microglia to produce these same pain-producing chemicals.

This may be one of the reasons why opioids are ineffective in patients with long-standing pain, as with fibromyalgia (FMS). Interestingly, drugs that block opioids, such as naltrexone, in very small doses have been found to be effective in decreasing pain in FMS (http://www.ncbi.nlm.nih.gov/pubmed/23359310). The mechanism appears to be blocking the pain producing effect of the microglia. Since the doses are so small (~4mg/day), the typical blocking of the mu receptor (the receptor that is known to be typically stimulated by opioids) doesn’t occur. What we often find as a result is pain relief and a decreasing need for opioids.

Since microglia also play an anti-inflammatory  role, in our search for drugs to affect the microglia, we need to find a balance in which we can maintain their protective anti-inflammatory roles while also reducing their inflammatory pain producing effects.  (http://www.nature.com/nrn/journal/v10/n1/abs/nrn2533.html)

Share

Treating widespread pain vs. the original pain generator

hip joint-Norman Marcus Pain Institute blogConsidering the possible effects of central sensitization may affect the treatment plan (and in turn the outcome) for a patient in pain.

For example, take someone who injured a joint – let’s say a hip – which led to osteoarthritis and in addition diffuse, widespread hyperalgesia (increased sensitivity to pain). Sometimes when a patient is in pain for a long period of time, we concentrate on the widespread pain rather than the original pain generator, the hip. These patients may be diagnosed with fibromyalgia because of their widespread pain, with treatment concentrated on that diagnosis. If the hip is treated (for example, a hip replacement), the widespread pain may resolve. This was demonstrated in a recent article, published in May 2013, that studied 40 patients. Patients who received hip replacements had normalization of their increased sensitivity  and elimination of their widespread pain. (http://www.ncbi.nlm.nih.gov/pubmed/23400951)

Let’s take a look at a contrasting scenario in my next blog.

Share

More on Fibromyalgia Syndrome (FMS)

I reread my blog on misleading diagnoses and central sensitization, and it confused me, so it must have confused some of you.   The point was that if so many of us have different interpretations of pain and how to treat it, we can’t all be right.Nonspecific Low Back Pain-10-8-13

I want to discuss specific pain syndromes where it is unclear what causes the pain. We have batted around some causes and possible explanations for Nonspecific Low Back Pain. I want to explore Fibromyalgia Syndrome (FMS), a condition characterized by widespread, diffuse pain on both sides of the body, above and below the waist.  In order to be diagnosed with FMS, patients must experience pain at a minimum of 11 out of 18 specified tender points, stiffness in joints, extreme fatigue, and difficulty sleeping.  Due to the diffuse nature of FMS, it is often difficult to pinpoint a specific pain generator.

In order to understand why we have problems identifying a significant source of pain, I am suggesting that we explore and understand central sensitization – the phenomenon of increased sensitivity of the central nervous system to all stimuli because of tissue damage somewhere in the periphery. This means that an injury at a peripheral site – for example, the hip or shoulder – can cause sensitivity in the central nervous system, which controls how we perceive and respond to stimuli.  This causes too much response for the amount of input – which means someone who is sensitized will experience pain in response to a stimulus that normally would not cause pain.

Share

Apparent diagnoses sometimes lead us astray …

When treating chronic back pain, over-reliance on imaging studies frequently suggest arthritis, disc herniations, spinal stenosis, degenerative disc disease, and spondylolisthesis as the underlying diagnoses. Unsuccessful treatment often results if muscles, tendons, and fascia are not considered in the differential diagnosis.

Widespread pain is often diagnosed as Fibromyalgia Syndrome (FMS). In 1990 the American College of Rheumatology (ACR) presented classification criteria for the diagnosis of FMS [http://bit.ly/1bCzlC4.] 11 of 18 specified tender points as well as widespread pain defined as pain experienced on the left and right side, in the upper and lower body, and axially. Most patients are diagnosed with FMS by their primary care physician. However, most primary care physicians do not perform a physical examination of tender points. Because of this the ACR in 2010 proposed an additional set of diagnostic criteria for FMS that did not rely on a physical examination (http://bit.ly/1bCzlC4).

Three conditions must be met to satisfy the criteria:

  1. Threshold scores on two new indices created by the ACR- the widespread pain index and the symptom severity scale score based on the presence of fatigue, waking un-refreshed and cognitive symptoms.
  2. Patients must have similar symptoms at approximately the same intensity for at least three months.
  3. No other disorder would reasonably explain the pain.

Although there is reasonable correlation between patients diagnosed with the 1990 criteria and the 2010 criteria, the absence of the physical examination may lead to overlooking patients whose diffuse pain can be successfully treated by addressing peripheral pain generators. Painful tissue peripherally (for example muscle or joint) can sensitize muscles diffusely [Woolf CJ, Central Sensitization: Implications for the diagnosis and treatment of pain. Pain 152 (2011) S2-S 15].

I welcome your comments on the complexities of diagnosing and treating FMS; more on central sensitization in my next post.

 

Share
NORMAN MARCUS PAIN INSTITUTE
30 East 40th Street - New York, NY 10016
Tel 212-532-7999 Fax 212-532-5957
Share
Help Desk Software